Children constitute the most challenging population in anti-HIV/AIDS pharmacotherapy. Efavirenz (EFV; aqueous solubility 4 µg/ml, bioavailability 40–45%) is a first-line agent in the pediatric ...

Abbreviated, 15- to 30-minute medication visits have become common in psychiatry now that many insurers model their ...

Pharmacotherapy is an effective, evidence-based treatment for people living with obesity, as part of a long-term, individualized treatment plan. An updated pharmacotherapy guideline for obesity ...

Background: Pharmacotherapy is a key component of comprehensive obesity management, alongside behavioural therapy and metabolic and bariatric surgery. In this guideline, we update the pharmacotherapy ...

Please provide your email address to receive an email when new articles are posted on . Addiction treatment best practices should include pharmacotherapy plus cognitive behavioral therapy or another ...

Substantial and sustained weight loss results in improvements in obesity-related comorbidities, and clinicians may consider pharmacotherapy and/or bariatric surgery in appropriate patients. Peter ...

Professor Carl V. Asche, M.B.A., M.Sc. (Health Economics), Ph.D. (Economics), has been appointed the Executive Director of the Pharmacotherapy Outcomes Research Center (PORC) at the University of Utah ...

In the primary care setting, long-term use of benzodiazepines is associated with many risks, including dependence and potential for abuse or misuse, excessive sedation, cognitive dysfunction, memory ...

The MS in Pharmacometrics and Personalized Pharmacotherapy is a new and unique graduate program focused on advanced training in pharmacometric principles of advanced pharmacokinetics (study of ...

“Pharmacotherapy can help people living with obesity improve overall health, not just lose weight,” says Dr. Sue D. Pedersen, MD, endocrinologist and obesity medicine specialist in Calgary, and lead ...